D. P. Ryan, T. S. Hong, N. Bardeesy, and . Pancreatic, N Engl J Med, vol.371, pp.1039-1088, 2014.

L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman et al., Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Cancer Res, vol.74, pp.2913-2934, 2014.

M. Malvezzi, P. Bertuccio, F. Levi, L. Vecchia, C. Negri et al., European cancer mortality predictions for the year 2014, Ann Oncol, vol.25, pp.1650-1656, 2014.

A. M. Bouvier, Z. Uhry, V. Jooste, A. Drouillard, A. Drouillard et al., Focus on an unusual rise in pancreatic cancer incidence in France, Int J Epidemiol, vol.46, pp.1764-72, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01541663

P. Maisonneuve and A. B. Lowenfels, Risk factors for pancreatic cancer: a summary review of meta-analytical studies, Int J Epidemiol, vol.44, pp.186-98, 2015.

M. Song and E. Giovannucci, Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States, JAMA Oncol, vol.2, pp.1154-61, 2016.

R. Huxley, A. Ansary-moghaddam, B. De-gonzález, A. Barzi, F. Woodward et al., Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies, Br J Cancer, vol.92, pp.2076-83, 2005.

M. A. Anderson, E. Zolotarevsky, K. L. Cooper, S. Sherman, O. Shats et al., Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study, Am J Gastroenterol, vol.107, pp.1730-1739, 2012.

P. Paluszkiewicz, K. Smoli?ska, I. D?bi?ska, and W. A. Turski, Main dietary compounds and pancreatic cancer risk. The quantitative analysis of casecontrol and cohort studies, Cancer Epidemiol, vol.36, pp.60-67, 2012.

L. Buscail, P. Faure, B. Bournet, J. Selves, and J. Escourrou, Interventional endoscopic ultrasound in pancreatic diseases, Pancreatology, vol.6, pp.7-16, 2006.

O. Banafea, F. P. Mghanga, J. Zhao, R. Zhao, and L. Zhu, Endoscopic ultrasonography with fine-needle aspiration for histological diagnosis of solid pancreatic masses: a meta-analysis of diagnostic accuracy studies, BMC Gastroenterol, vol.16, p.108, 2016.

H. A. Burris, M. J. Moore, J. Andersen, M. R. Green, M. L. Rothenberg et al., Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial, J Clin Oncol, vol.15, pp.2403-2416, 1997.

T. Conroy, F. Desseigne, M. Ychou, O. Bouché, R. Guimbaud et al., FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer, N Engl J Med, vol.364, pp.1817-1842, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00598658

V. Hoff, D. D. Ervin, T. Arena, F. P. Chiorean, E. G. Infante et al., Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine, N Engl J Med, vol.369, pp.1691-703, 2013.

B. Bournet, A. Souque, P. Senesse, E. Assenat, M. Barthet et al., Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis, Endoscopy, vol.41, pp.552-559, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410404

B. Bournet, F. Muscari, C. Buscail, E. Assenat, M. Barthet et al., KRAS G12D mutation subtype is a prognostic factor for advanced pancreatic adenocarcinoma, Clin Transl Gastroenterol, vol.7, p.157, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01301141

K. C. Sonntag, G. Tejada, S. Subburaju, S. Berretta, F. M. Benes et al., Limited predictability of postmortem human brain tissue quality by RNA integrity numbers, J Neurochem, vol.138, pp.53-62, 2016.

J. I. Davila, N. M. Fadra, X. Wang, A. M. Mcdonald, A. A. Nair et al., Impact of RNA degradation on fusion detection by RNA-seq, BMC Genomics, vol.17, p.814, 2016.

M. Humeau, A. Vignolle-vidoni, F. Sicard, F. Martins, B. Bournet et al., Salivary MicroRNA in pancreatic Cancer patients, PLoS One, vol.10, p.130996, 2015.

A. V. Biankin, N. Waddell, K. S. Kassahn, M. C. Gingras, L. B. Muthuswamy et al., Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes, Nature, vol.491, pp.399-405, 2012.

N. Waddell, M. Pajic, A. M. Patch, D. K. Chang, K. S. Kassahn et al., Whole genomes redefine the mutational landscape of pancreatic cancer, Nature, vol.518, pp.495-501, 2015.

P. Bailey, D. K. Chang, K. Nones, A. L. Johns, A. M. Patch et al., Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016.

M. J. Demeure, T. Sielaff, L. Koep, R. Prinz, J. Moser et al., Multiinstitutional tumor banking -lessons learned from a pancreatic cancer biospecimen repository, Pancreas, vol.7, pp.949-54, 2010.